✦ LIBER ✦

A phase II study of cisplatin, carboplatin and methotrexate in patients with metastatic or locally recurrent transitional cell carcinoma of the urothelium

✍ Scribed by Sengeløv, L; Nielsen, OS; Kamby, C; von der Maase, H

Book ID: 123248913
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 157 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91917-A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of cisplatin plus metho

A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium

✍ Flemming Geertsen, Poul; Sengeløv, Lisa; Kornum Larsen, Susanne; von der Maase, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 561 KB

A prognostic index in patients with meta

A prognostic index in patients with metastatic or recurrent transitional cell carcinoma of the urothelium (TCU)

✍ Sengeløv, L; Kamby, C; von der Maase, H 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase II Study of Carboplatin in Locally

Phase II Study of Carboplatin in Locally Advanced and Metastatic Transitional Cell Carcinoma of the Urinary Bladder

✍ N. K. RAABE; SOPHIE D. FOSSÅ; G. PARØ 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Methotrexate-paclitaxel-epirubicin-carbo

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

✍ Amal Halim; Niveen Abotouk 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

COMBINATION CHEMOTHERAPY FOR METASTATIC

COMBINATION CHEMOTHERAPY FOR METASTATIC OR LOCALLY ADVANCED GENITOURINARY SQUAMOUS CELL CARCINOMA: A PHASE II STUDY OF METHOTREXATE, CISPLATIN AND BLEOMYCIN

✍ CORRAL, DAVID A.; SELLA, AVISHAY; PETTAWAY, CURTIS A.; AMATO, ROBERT J.; JONES, 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 807 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra